Point-of-care diagnostics for invasive aspergillosis: nearing the finish line.

Loading...
Thumbnail Image

Date

2020-10

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

4
views
7
downloads

Citation Stats

Abstract

Introduction

The spectrum of disease caused by Aspergillus spp. is dependent on the immune system of the host, with invasive aspergillosis (IA) its most severe manifestation. Early and reliable diagnosis of Aspergillus disease is important to decrease associated morbidity and mortality from IA.

Areas covered

The following review searched Pub Med for literature published since 2007 and will give an update on the current point-of-care diagnostic strategies for the diagnosis of IA, discuss needed areas of improvement for these tests, and future directions.

Expert opinion

Several new diagnostic tests for IA - including point-of-care tests - are now available to complement conventional galactomannan (GM) testing. In particular, the Aspergillus-specific Lateral Flow Device (LFD) test and the sōna Aspergillus GM Lateral Flow Assay (LFA) are promising for the diagnosis of IA in patients with hematologic malignancy, although further evaluation in the non-hematology setting is needed. In addition, a true point-of-care test, particularly for easily obtained specimens like serum or urine that can be done at the bedside or in the Clinic in a matter of minutes is needed, such as the lateral flow dipstick test, which is under current evaluation. Lastly, improved diagnostic algorithms to diagnose IA in non-neutropenic patients is needed.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1080/14737159.2020.1820864

Publication Info

Jenks, Jeffrey D, and Martin Hoenigl (2020). Point-of-care diagnostics for invasive aspergillosis: nearing the finish line. Expert review of molecular diagnostics, 20(10). pp. 1009–1017. 10.1080/14737159.2020.1820864 Retrieved from https://hdl.handle.net/10161/28620.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Jenks

Jeffrey Daniel Jenks

Adjunct Associate Professor in the Department of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.